Decapharma SRL
0.5 FTEThe score of Decapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -4 % Total assets +10 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,351 € | ||||
| Equity | 105,083 € | ||||
| Cash | 45,448 € | ||||
| EBITDA | 39,490 € | ||||
| Total assets | 291,134 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 28 Jan 2026
- Year ended 30 Jun 2024filed on 27 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 25 Jan 2023
- Year ended 30 Jun 2021filed on 21 Jan 2022
Decapharma's financial analysis
- Solvency36.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decapharma
Decapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0828.116.714
- VAT number
- BE0828116714
- Peppol
- Registered · 0208:0828116714 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jul 2010
- Registered office
- 8301 Knokke-Heist
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 28 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Decapharma (SRL) has been based in Knokke-Heist since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,351 € and equity of 105,083 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 36.1%, below the median of its sector (44.2%).
Companies similar to Decapharma
Companies in the same business, of comparable size and area, outside its group.
- Swilem Pharmaceuticals Business and other management consultancy activities Evere · balance sheet 292,979 €
- Berghman Business and other management consultancy activities Wervik · balance sheet 426,772 €
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- BERA Business and other management consultancy activities Antwerp · balance sheet 140,519 €
- Nimy Phar Retail sale of pharmaceutical products Mons · balance sheet 259,917 €
- Pharmacie DE Rienne Retail sale of pharmaceutical products Gembloux · balance sheet 334,259 €
- Futurophar Retail sale of pharmaceutical products Ghent · balance sheet 394,606 €
- Libo Consult Retail sale of pharmaceutical products Halen · balance sheet 516,567 €
Frequently asked questions about Decapharma
What is the revenue of Decapharma?
Decapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Decapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0828116714 for Decapharma, if the company is VAT-registered. Its company number (CBE) is 0828.116.714.
Where is the registered office of Decapharma?
According to the CBE register, the registered office of Decapharma is in 8301 Knokke-Heist.
What is the equity of Decapharma?
At the close of the 2025 financial year, the equity of Decapharma amounts to 105,083 €, a solvency of 36.1% of total assets.
How many people work at Decapharma?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Decapharma?
The register lists 2 active mandates at Decapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →